This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Astellas Pharma, Inc.

Drug Names(s): YM543

Description: YM543 is a SGLT2 inhibitor.

Deal Structure: YM543 is being codeveloped with Kotobuki Pharmaceuticals. Details of the partnership were not disclosed.

Partners: Kotobuki Pharmaceutical Co., Ltd.

YM543 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug